Light Therapy in Parkinson's Disease
The aim of this randomized controlled trial (RCT) is to clarify the effect of bright light therapy on motor symptoms and sleep disorders in patients with Parkinson's disease.
Study identifier: NCT06129942. Status: RECRUITING. Phase: NA.
Eligibility
Criteria: Inclusion Criteria: * According to the criteria of PD diagnosis of the MDS, PD patients were selected as the research object. The clinical symptoms of PD patients were consistent with Hoehn and Yahr stages 2-3. * All PD patients have maintained stable drug treatment for at least one month, signed clinical informed consent and agreed not to adjust drugs throughout the light test and follow-up period. Exclusion Criteria: * Using hypnotic or stimulating drugs. * Using antidepressants, except stable drugs maintained for more than three months; * Visual impairment, such as cataract, glaucoma, blindness, etc; * Cognitive impairment (MMSE \< 24); * There are uncontrollable hallucinations and mental diseases; * There are sleep phase delay / advance syndrome, shift work, jet lag, etc
- Minimum age: 50 Years
- Maximum age: 80 Years
Participating locations
- Department of Neurology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu
Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.